These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3081819)

  • 1. Cause of the 'inhibitor' phenotype in the haemophilias.
    Giannelli F; Brownlee GG
    Nature; 1986 Mar 13-19; 320(6058):196. PubMed ID: 3081819
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients with hemophilia B (Christmas disease) who have anti-factor IX: genetic heterogeneity.
    Poon MC
    J Lab Clin Med; 1988 Sep; 112(3):283-4. PubMed ID: 3411190
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemophilia B+ with inhibitor.
    Ludwig M; Schwaab R; Olek K; Brackmann HH; Egli H
    Thromb Haemost; 1988 Apr; 59(2):340. PubMed ID: 3388303
    [No Abstract]   [Full Text] [Related]  

  • 4. The molecular basis of severe hemophilia B in a girl.
    Nisen P; Stamberg J; Ehrenpreis R; Velasco S; Shende A; Engelberg J; Karayalcin G; Waber L
    N Engl J Med; 1986 Oct; 315(18):1139-42. PubMed ID: 3093864
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of genetics in inhibitor formation.
    Gill JC
    Thromb Haemost; 1999 Aug; 82(2):500-4. PubMed ID: 10605742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic view on the etiology of the inhibitor complication.
    Giannelli F; Green PM; Naylor JA
    Blood; 1996 Mar; 87(6):2612. PubMed ID: 8630434
    [No Abstract]   [Full Text] [Related]  

  • 8. [DNA analysis in the inhibitor phenotype of the hemophilias].
    Yamamoto K; Takahashi I
    Rinsho Ketsueki; 1993 May; 34(5):578-82. PubMed ID: 8315828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.
    DiMichele DM
    Haemophilia; 2006 Dec; 12 Suppl 6():37-41; discussion 41-2. PubMed ID: 17123392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients.
    Chuansumrit A; Sasanakul W; Sirachainan N; Kadegasem P; Wongwerawattanakoon P; Mahaklan L; Nathalang O
    Haemophilia; 2017 Nov; 23(6):e518-e523. PubMed ID: 28891589
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX gene.
    Hassan HJ; Leonardi A; Guerriero R; Chelucci C; Cianetti L; Ciavarella N; Ranieri P; Pilolli D; Peschle C
    Blood; 1985 Sep; 66(3):728-30. PubMed ID: 2992643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

  • 13. The molecular basis of haemophilia A and B.
    Giannelli F; Green PM
    Baillieres Clin Haematol; 1996 Jun; 9(2):211-28. PubMed ID: 8800501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA analysis of seven patients with hemophilia B who have anti-factor IX antibodies: relationship to clinical manifestations and evidence that the abnormal gene was inherited.
    Tanimoto M; Kojima T; Kamiya T; Takamatsu J; Ogata K; Obata Y; Inagaki M; Iizuka A; Nagao T; Kurachi K
    J Lab Clin Med; 1988 Sep; 112(3):307-13. PubMed ID: 3411192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial deletion by illegitimate recombination of the factor IX gene in a haemophilia B family with two inhibitor patients.
    Green PM; Bentley DR; Mibashan RS; Giannelli F
    Mol Biol Med; 1988 Apr; 5(2):95-106. PubMed ID: 3398774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
    Keeling D; Beavis J; Sukhu K
    Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of inhibitors.
    Astermark J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.
    Astermark J
    Haemophilia; 2006 Jul; 12 Suppl 3():52-60. PubMed ID: 16683997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.